{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T01:08:24Z","timestamp":1782436104500,"version":"3.54.5"},"reference-count":68,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Protein kinase CK2 has emerged as a pivotal regulator of cellular processes involved in skin homeostasis, including cell proliferation, differentiation and inflammatory response regulation. In fact, CK2 activity dysregulation is implicated in the pathogenesis of different skin diseases, such as psoriasis, cancer and inflammatory dermatoses. CK2 overactivation fosters keratinocyte proliferation and pro-inflammatory cytokine production through the STAT3 and Akt pathways in psoriasis, thus contributing to epidermal hyperplasia and inflammation. In the realm of oncology, CK2 overexpression correlates with tumor progression, facilitating cell survival and metastasis in melanoma and non-melanoma skin cancers. Pharmacological inhibition of CK2 has demonstrated therapeutic potential, with CX-4945 (Silmitasertib) as the most studied adenosine triphosphate-competitive inhibitor (ATP-competitive inhibitor). Preclinical models reveal that CK2 inhibitors effectively mitigate pathological features of psoriasis, regulate keratinocyte differentiation, and suppress tumor growth in skin cancers. These inhibitors also potentiate the efficacy of conventional chemotherapeutics and exhibit anti-inflammatory effects in dermatological conditions. Future research will aim to enhance the specificity and delivery of CK2-targeting therapies, including topical formulations, to minimize systemic side effects. Combination therapies integrating CK2 inhibitors with other agents might offer synergistic benefits in managing skin diseases. This review underscores CK2\u2019s critical role in skin and its therapeutic potential as a pharmacological target, advocating for innovative approaches to harness CK2 inhibition in dermatology.<\/jats:p>","DOI":"10.3390\/ijms26115404","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T11:14:12Z","timestamp":1749035652000},"page":"5404","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Protein Kinase CK2 Inhibition Represents a Pharmacological Chance for the Treatment of Skin Diseases"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5282-1690","authenticated-orcid":false,"given":"Michele","family":"Scuruchi","sequence":"first","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Messina, Via C. Valeria, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5108-1052","authenticated-orcid":false,"given":"Desir\u00e8e","family":"Speranza","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Messina, Via C. Valeria, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9065-4467","authenticated-orcid":false,"given":"Giuseppe","family":"Bruschetta","sequence":"additional","affiliation":[{"name":"Department of Veterinary Sciences, University of Messina, Viale G. Palatucci, 98168 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Vaccaro","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Dental Sciences and Morphological and Functional Imaging, University of Messina, Via C. Valeria, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariarosaria","family":"Galeano","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Dental Sciences and Morphological and Functional Imaging, University of Messina, Via C. Valeria, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4187-2265","authenticated-orcid":false,"given":"Giovanni","family":"Pallio","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Dental Sciences and Morphological and Functional Imaging, University of Messina, Via C. Valeria, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3787-5145","authenticated-orcid":false,"given":"Mario","family":"Vaccaro","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Messina, Via C. Valeria, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3515-8441","authenticated-orcid":false,"given":"Francesco","family":"Borgia","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Messina, Via C. Valeria, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6760-9468","authenticated-orcid":false,"given":"Federica","family":"Li Pomi","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Messina, Via C. Valeria, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8782-3496","authenticated-orcid":false,"given":"Massimo","family":"Collino","sequence":"additional","affiliation":[{"name":"Department of Neurosciences \u201cRita Levi Montalcini\u201d, University of Torino, Via Verdi, 10124 Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Irrera","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Messina, Via C. Valeria, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41572-025-00603-8","article-title":"Cutaneous melanoma","volume":"11","author":"Tasdogan","year":"2025","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Halloran, D., Pandit, V., and Nohe, A. (2022). The Role of Protein Kinase CK2 in Development and Disease Progression: A Critical Review. J. Dev. Biol., 10.","DOI":"10.3390\/jdb10030031"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41392-021-00567-7","article-title":"Protein kinase CK2: A potential therapeutic target for diverse human diseases","volume":"6","author":"Borgo","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ajpath.2023.01.016","article-title":"Protein Kinase CK2 Promotes Proliferation, Abnormal Differentiation, and Proinflammatory Cytokine Production of Keratinocytes via Regulation of STAT3 and Akt Pathways in Psoriasis","volume":"193","author":"Huang","year":"2023","journal-title":"Am. J. Pathol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s13402-020-00566-w","article-title":"Role of CK2 inhibitor CX-4945 in anti-cancer combination therapy-potential clinical relevance","volume":"43","author":"Borgo","year":"2020","journal-title":"Cell. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.bbrc.2011.10.046","article-title":"Protein kinase CK2 modulates IL-6 expression in inflammatory breast cancer","volume":"415","author":"Drygin","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_8","first-page":"383","article-title":"A historical view of protein kinase CK2","volume":"40","author":"Pinna","year":"1994","journal-title":"Cell. Mol. Biol. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1242\/jcs.00074","article-title":"Protein kinase CK2: A challenge to canons","volume":"115","author":"Pinna","year":"2002","journal-title":"J. Cell Sci."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Montenarh, M., and G\u00f6tz, C. (2023). Protein Kinase CK2\u03b1\u2032, More than a Backup of CK2\u03b1. Cells, 12.","DOI":"10.3390\/cells12242834"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0014-5793(99)01553-7","article-title":"Protein kinase CK2: Evidence for a protein kinase CK2beta subunit fraction, devoid of the catalytic CK2alpha subunit, in mouse brain and testicles","volume":"462","author":"Guerra","year":"1999","journal-title":"FEBS Lett."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"6660","DOI":"10.1016\/S0021-9258(17)39899-X","article-title":"Purification of rat liver nuclear protein kinase NII","volume":"252","author":"Thornburg","year":"1977","journal-title":"J. Biol. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0079-6603(03)01015-8","article-title":"The genes encoding human protein kinase CK2 and their functional links","volume":"74","author":"Pyerin","year":"2003","journal-title":"Prog. Nucleic Acid Res. Mol. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1006\/geno.1994.1032","article-title":"Assignment of the human casein kinase II alpha\u2032 subunit gene (CSNK2A1) to chromosome 16p13.2-p13.3","volume":"19","author":"Naiman","year":"1994","journal-title":"Genomics"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1021\/ar020164f","article-title":"The raison d\u2019\u00eatre of constitutively active protein kinases: The lesson of CK2","volume":"36","author":"Pinna","year":"2003","journal-title":"Acc. Chem. Res."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Spinello, Z., Fregnani, A., Quotti Tubi, L., Trentin, L., Piazza, F., and Manni, S. (2021). Targeting Protein Kinases in Blood Cancer: Focusing on CK1\u03b1 and CK2. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22073716"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/sj.cdd.4401604","article-title":"Protein kinase CK2 phosphorylates and upregulates Akt\/PKB","volume":"12","author":"Salvi","year":"2005","journal-title":"Cell Death Differ."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jbior.2017.03.002","article-title":"Cross-talk between the CK2 and AKT signaling pathways in cancer","volume":"64","author":"Ruzzene","year":"2017","journal-title":"Adv. Biol. Regul."},{"key":"ref_19","first-page":"685","article-title":"Protein kinase CK2 subunits are positive regulators of AKT kinase","volume":"28","author":"Guerra","year":"2006","journal-title":"Int. J. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"20533","DOI":"10.1021\/ja310214g","article-title":"Ordered phosphorylation events in two independent cascades of the PTEN C-tail revealed by NMR","volume":"134","author":"Cordier","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jbior.2016.09.003","article-title":"Regulation of cellular proliferation in acute lymphoblastic leukemia by Casein Kinase II (CK2) and Ikaros","volume":"63","author":"Gowda","year":"2017","journal-title":"Adv. Biol. Regul."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S1097-2765(03)00358-7","article-title":"CK2 Is a C-Terminal IkappaB Kinase Responsible for NF-kappaB Activation during the UV Response","volume":"12","author":"Kato","year":"2003","journal-title":"Mol. Cell"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"32592","DOI":"10.1074\/jbc.M001358200","article-title":"Tumor necrosis factor alpha-induced phosphorylation of RelA\/p65 on Ser529 is controlled by casein kinase II","volume":"275","author":"Wang","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00384-006-0193-7","article-title":"The role of protein kinase CK2 in intestinal epithelial cell inflammatory signaling","volume":"22","author":"Parhar","year":"2007","journal-title":"Int. J. Color. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11010-016-2765-3","article-title":"Examination of CK2\u03b1 and NF-\u03baB p65 expression in human benign prostatic hyperplasia and prostate cancer tissues","volume":"420","author":"Qaiser","year":"2016","journal-title":"Mol. Cell. Biochem."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Trembley, J.H., Kren, B.T., Abedin, M.J., Shaughnessy, D.P., Li, Y., Dehm, S.M., and Ahmed, K. (2019). CK2 Pro-Survival Role in Prostate Cancer Is Mediated via Maintenance and Promotion of Androgen Receptor and NF\u03baB p65 Expression. Pharmaceuticals, 12.","DOI":"10.3390\/ph12020089"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1182\/blood-2011-05-352542","article-title":"JAKs, Stats, and CK2?","volume":"118","author":"Argetsinger","year":"2011","journal-title":"Blood"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1182\/blood-2010-01-266320","article-title":"A CK2-dependent mechanism for activation of the JAK-STAT signaling pathway","volume":"118","author":"Zheng","year":"2011","journal-title":"Blood"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11010-005-3078-0","article-title":"CK2 as a positive regulator of Wnt signalling and tumourigenesis","volume":"274","author":"Seldin","year":"2005","journal-title":"Mol. Cell. Biochem."},{"key":"ref_30","first-page":"59","article-title":"Has protein kinase CK2 a role in the intracellular mitogenic signalling?","volume":"189","author":"Filhol","year":"1995","journal-title":"Comptes Rendus Seances Soc. Biol. Fil."},{"key":"ref_31","first-page":"529","article-title":"Casein kinase 2 and the cell response to growth factors","volume":"40","author":"Cochet","year":"1994","journal-title":"Cell. Mol. Biol. Res."},{"key":"ref_32","first-page":"555","article-title":"A novel system to investigate the phosphorylation of the p53 tumor suppressor protein by the protein kinase CK2","volume":"40","author":"McKendrick","year":"1994","journal-title":"Cell. Mol. Biol. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1023\/A:1006854109926","article-title":"Protein kinase CK2-dependent regulation of p53 function: Evidence that the phosphorylation status of the serine 386 (CK2) site of p53 is constitutive and stable","volume":"191","author":"McKendrick","year":"1999","journal-title":"Mol. Cell. Biochem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"37218","DOI":"10.1074\/jbc.M110.174565","article-title":"Casein kinase 2 promotes Hedgehog signaling by regulating both smoothened and Cubitus interruptus","volume":"285","author":"Jia","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"192","DOI":"10.5483\/BMBRep.2022.55.4.021","article-title":"Casein kinase 2 promotes the TGF-\u03b2-induced activation of \u03b1-tubulin acetyltransferase 1 in fibroblasts cultured on a soft matrix","volume":"55","author":"You","year":"2022","journal-title":"BMB Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41419-022-04523-3","article-title":"Advances in the pathogenesis of psoriasis: From keratinocyte perspective","volume":"13","author":"Zhou","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_37","first-page":"83","article-title":"Key Signaling Pathways in Psoriasis: Recent Insights from Antipsoriatic Therapeutics","volume":"11","author":"Johansen","year":"2021","journal-title":"Psoriasis"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.intimp.2010.06.004","article-title":"Diosgenin inhibits macrophage-derived inflammatory mediators through downregulation of CK2, JNK, NF-kappaB and AP-1 activation","volume":"10","author":"Jung","year":"2010","journal-title":"Int. Immunopharmacol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1002\/ptr.6597","article-title":"The regulation of protein kinase casein kinase II by apigenin is involved in the inhibition of ultraviolet B-induced macrophage migration inhibitory factor-mediated hyperpigmentation","volume":"34","author":"Yoshihisa","year":"2020","journal-title":"Phytother. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF00373381","article-title":"Casein kinase II activity in psoriatic epidermis","volume":"284","author":"Mitev","year":"1992","journal-title":"Arch. Dermatol. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s13770-018-0145-7","article-title":"Keratinocyte Migration in a Three-Dimensional In Vitro Wound Healing Model Co-Cultured with Fibroblasts","volume":"15","author":"Iyer","year":"2018","journal-title":"Tissue Eng. Regen. Med."},{"key":"ref_42","first-page":"202","article-title":"Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J. Rheumatol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Mouawad, J.E., and Feghali-Bostwick, C. (2023). The Molecular Mechanisms of Systemic Sclerosis-Associated Lung Fibrosis. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24032963"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1136\/annrheumdis-2013-204256","article-title":"Inhibition of casein kinase II reduces TGF\u03b2 induced fibroblast activation and ameliorates experimental fibrosis","volume":"74","author":"Zhang","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1002\/1878-0261.12378","article-title":"Protein kinase CK2 activation is required for transforming growth factor \u03b2-induced epithelial-mesenchymal transition","volume":"12","author":"Kim","year":"2018","journal-title":"Mol. Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Mathew-Steiner, S.S., Roy, S., and Sen, C.K. (2021). Collagen in Wound Healing. Bioengineering, 8.","DOI":"10.3390\/bioengineering8050063"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"9691","DOI":"10.1007\/s11033-023-08708-7","article-title":"CK2 inhibitor CX4945 inhibits collagen degradation of HaCaT human keratinocyte cells via attenuation of MMP-1 secretion","volume":"50","author":"Jeon","year":"2023","journal-title":"Mol. Biol. Rep."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"100962","DOI":"10.1016\/j.mcpro.2025.100962","article-title":"Cold Atmospheric Plasma Jet Promotes Wound Healing Through CK2-Coordinated PI3K\/AKT and MAPK Signaling Pathways","volume":"24","author":"Wu","year":"2025","journal-title":"Mol. Cell. Proteom. MCP"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Firnau, M.B., and Brieger, A. (2022). CK2 and the Hallmarks of Cancer. Biomedicines, 10.","DOI":"10.3390\/biomedicines10081987"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cpt.2024.08.002","article-title":"Overview of skin cancer types and prevalence rates across continents","volume":"3","author":"Roky","year":"2025","journal-title":"Cancer Pathog. Ther."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Azimi, A., Caramuta, S., Seashore-Ludlow, B., Bostr\u00f6m, J., Robinson, J.L., Edfors, F., Tuominen, R., Kemper, K., Krijgsman, O., and Peeper, D.S. (2018). Targeting CDK2 overcomes melanoma resistance against BRAF and Hsp90 inhibitors. Mol. Syst. Biol., 14.","DOI":"10.15252\/msb.20177858"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ccr.2009.02.022","article-title":"Oncogenic Braf induces melanocyte senescence and melanoma in mice","volume":"15","author":"Dhomen","year":"2009","journal-title":"Cancer Cell"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Li Pomi, F., Borgia, F., Custurone, P., Vaccaro, M., Pioggia, G., and Gangemi, S. (2022). Role of HMGB1 in Cutaneous Melanoma: State of the Art. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23169327"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Chua, M.M., Ortega, C.E., Sheikh, A., Lee, M., Abdul-Rassoul, H., Hartshorn, K.L., and Dominguez, I. (2017). CK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target. Pharmaceuticals, 10.","DOI":"10.3390\/ph10010018"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1158\/1078-0432.CCR-15-1314","article-title":"Molecular Pathways: Emergence of Protein Kinase CK2 (CSNK2) as a Potential Target to Inhibit Survival and DNA Damage Response and Repair Pathways in Cancer Cells","volume":"22","author":"Rabalski","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41392-025-02142-w","article-title":"Wnt signaling pathways in biology and disease: Mechanisms and therapeutic advances","volume":"10","author":"Xue","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jid.2022.09.658","article-title":"FZD6 Promotes Melanoma Cell Invasion but Not Proliferation by Regulating Canonical Wnt Signaling and Epithelial\u2014Mesenchymal Transition","volume":"143","author":"Dong","year":"2023","journal-title":"J. Investig. Dermatol."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Wang, H., Zhang, H., Chen, Y., Wang, H., Tian, Y., Yi, X., Shi, Q., Zhao, T., Zhang, B., and Gao, T. (2022). Targeting Wnt\/\u03b2-Catenin Signaling Exacerbates Ferroptosis and Increases the Efficacy of Melanoma Immunotherapy via the Regulation of MITF. Cells, 11.","DOI":"10.3390\/cells11223580"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"110938","DOI":"10.1016\/j.cellsig.2023.110938","article-title":"RIPK4 downregulation impairs Wnt3A-stimulated invasiveness via Wnt\/\u03b2-catenin signaling in melanoma cells and tumor growth in vivo","volume":"113","author":"Wronski","year":"2024","journal-title":"Cell Signal."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.ccr.2011.10.030","article-title":"\u03b2-catenin signaling controls metastasis in Braf-activated Pten-deficient melanomas","volume":"20","author":"Damsky","year":"2011","journal-title":"Cancer Cell"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3892\/etm.2023.12115","article-title":"Advances in targeted therapy and immunotherapy for melanoma (Review)","volume":"26","author":"Qin","year":"2023","journal-title":"Exp. Ther. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"17804","DOI":"10.1074\/jbc.M115.712885","article-title":"Protein Kinase CK2\u03b1 Maintains Extracellular Signal-regulated Kinase (ERK) Activity in a CK2\u03b1 Kinase-independent Manner to Promote Resistance to Inhibitors of RAF and MEK but Not ERK in BRAF Mutant Melanoma","volume":"291","author":"Zhou","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1158\/1535-7163.MCT-13-0938","article-title":"Phosphoproteomics of MAPK inhibition in BRAF-mutated cells and a role for the lethal synergism of dual BRAF and CK2 inhibition","volume":"13","author":"Parker","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Alkassis, S., Shatta, M., and Wong, D.J. (2024). Therapeutic Advances in Advanced Basal Cell Carcinoma. Cancers, 16.","DOI":"10.3390\/cancers16173075"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"AB10","DOI":"10.1016\/j.jaad.2022.06.074","article-title":"32283 A phase I study of CX-4945 administered orally twice daily to patients with advanced basal cell carcinoma","volume":"87","author":"McCormick","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"117048","DOI":"10.1016\/j.ejmech.2024.117048","article-title":"Discovery of a novel, selective CK2 inhibitor class with an unusual basic scaffold","volume":"282","author":"Khalifa","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/bs.apcsb.2020.09.003","article-title":"Protein kinase CK2 inhibition as a pharmacological strategy","volume":"124","author":"Borgo","year":"2021","journal-title":"Adv. Protein Chem. Struct. Biol."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Zhang, Y., and Jiang, G. (2024). Application of JAK inhibitors in paradoxical reaction through immune-related dermatoses. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1341632"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/11\/5404\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:46:46Z","timestamp":1760032006000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/11\/5404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":68,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["ijms26115404"],"URL":"https:\/\/doi.org\/10.3390\/ijms26115404","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]}}}